Cancer aftercare in general practice - A blended lifestyle medicine approach

Recruiting

Conditions: malignant neoplasm and cancer
10027656

Registration Number: NL-OMON51779

Lead Sponsor: Open Universiteit

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Not specified

Target Recruitment: 376

Inclusion Criteria

a) Patients who have successfully completed the primary treatment for cancer
(e.g. radiotherapy, chemotherapy, surgery) and were treated with curative
intent, with the last treatment to have been between 6 weeks ago and 3 years
ago, or belong to a watchful waiting condition (e.g. option for prostate cancer
patients)
b) 18 years of age and older
c) Able to read and speak Dutch
d) Without a serious medical, psychiatric or cognitive disease that would
interfere with participation
e) Internet access and at least minimal internet experience
f) Access to a computer or tablet

Exclusion Criteria

a) Patients with a serious medical, psychiatric, or cognitive disease that
would interfere with participation (e.g. Alzheimer*s disease, blindness);
b) Patients who did not complete primary treatment or who were not treated with
curative intent

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcomes at baseline, 6 months and 12 months are effects on lifestyle<br /><br>behaviors:<br /><br>1) Physical activity: the amount of minutes per week of moderate physical<br /><br>activity, number of muscle strengthening exercises<br /><br>2) Smoking<br /><br>3) Alcohol use<br /><br>4) Diet: weekly intake of vegetables, fruit, fiber and fish</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcomes at 6 months are biomarkers:<br /><br>- Blood pressure<br /><br><br /><br>Secondary outcomes at baseline, 6 months and 12 months are:<br /><br>- Experienced distress (depression and anxiety)<br /><br>- Experience fatigue<br /><br>- Health related quality of life<br /><br><br /><br>Secondary outcomes at 6 months are:<br /><br>- Disease burden<br /><br>- Medical consumption<br /><br>- Productivity costs<br /><br>- QALY*s<br /><br>- Appreciation and use of the intervention</p><br>